Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
2.480
+0.150 (6.44%)
At close: Jun 20, 2025, 4:00 PM
2.452
-0.029 (-1.15%)
After-hours: Jun 20, 2025, 7:50 PM EDT
Atai Life Sciences Stock Forecast
Stock Price Forecast
The 3 analysts that cover Atai Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $10.5, which forecasts a 323.39% increase in the stock price over the next year. The lowest target is $10 and the highest is $11.
Price Target: $10.5 (+323.39%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2025.
Analyst Ratings
The average analyst rating for Atai Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +303.23% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +303.23% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +303.23% | Feb 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +303.23% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +303.23% | Jan 28, 2025 |
Financial Forecast
Revenue This Year
2.02M
from 308.00K
Increased by 554.22%
Revenue Next Year
382.50K
from 2.02M
Decreased by -81.02%
EPS This Year
-0.54
from -0.93
EPS Next Year
-0.59
from -0.54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.3M | 1.6M | 230.3M | ||
| Avg | 2.0M | 382,500 | 80.2M | ||
| Low | 1.6M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 956.8% | -21.8% | 60,101.3% | ||
| Avg | 554.2% | -81.0% | 20,862.9% | ||
| Low | 409.1% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.44 | -0.38 | -0.34 | ||
| Avg | -0.54 | -0.59 | -0.50 | ||
| Low | -0.59 | -0.90 | -0.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.